Acute gastritis

K11_ACUTGASTR

chronic gastritis: Inflammation of the stomach that is chronic in nature.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K29.0, K29.1 Hospital discharge: ICD-9 — 5350 Hospital discharge: ICD-8 — 3530[0-2] Cause of death: ICD-10 — K29.0, K29.1 Cause of death: ICD-9 — 5350 Cause of death: ICD-8 — 3530[0-2] 2 out of 7 registries used, show all original rules.	3275
4. Check minimum number of events None	3275
5. Include endpoints None	3275
6. Filter based on genotype QC (FinnGen only)	3178

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_ACUTGASTR
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K29[0-1]
HD_ICD_9	5350
HD_ICD_8	3530[0-2]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K29[0-1]
COD_ICD_9	5350
COD_ICD_8	3530[0-2]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute gastritis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	29046	14553	14180
Only index persons	22721	11717	11004
Unadjusted period prevalence (%)
Whole population	0.41	0.42	0.40
Only index persons	0.43	0.43	0.42
Median age at first event (years)
Whole population	59.00	62.12	55.63
Only index persons	55.57	58.04	52.93

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3178	1676	1502
Unadjusted period prevalence (%)	0.64	0.59	0.69
Median age at first event (years)	56.65	54.33	59.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3275: Matched controls
32750

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.9

320.7

1652

6775

A02BC05

ATC

esomeprazole; systemic

3.9

317.3

1803

7880

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

45.8

308.1

182

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

12.2

307.7

416

385

5350A

ICD-9 Finland

Gastritis and duodenitis, Acute gastritis

+∞

307.7

393

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3390.1

307.7

1015

A02BC03

ATC

lansoprazole; oral

4.1

307.7

1482

5464

K29.7

ICD-10 Finland

Gastritis, unspecified

26.1

307.7

238

K29.1

ICD-10 Finland

Other acute gastritis

2292.8

307.7

1911

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

28.7

307.7

556

232

K29.3

ICD-10 Finland

Chronic superficial gastritis

87.6

307.7

190

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

15.0

307.7

2084

3413

UJD02

NOMESCO Finland

Gastroscopy

11.0

307.4

343

344

K30

ICD-10 Finland

Functional dyspepsia

6.2

262.6

500

931

UJF32

NOMESCO Finland

Coloscopy

3.6

262.4

1279

4929

A02BC01

ATC

omeprazole; systemic

3.5

254.3

1308

5198

A02BA02

ATC

ranitidine; systemic

3.8

250.3

1014

3445

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

6.9

250.1

416

675

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.8

215.2

824

2666

K92.0

ICD-10 Finland

Haematemesis

12.8

203.6

201

166

A02BC02

ATC

pantoprazole; systemic

3.6

202.7

2575

16632

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

106.3

200.0

103

K92.1

ICD-10 Finland

Melaena

5.4

147.4

312

631

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

134.1

1147

5659

K29.4

ICD-10 Finland

Chronic atrophic gastritis

27.5

133.6

N02AX02

ATC

tramadol; systemic, rectal

2.4

128.7

1643

9679

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

65.0

127.0

K29.6

ICD-10 Finland

Other gastritis

41.5

120.9

A03FA02

ATC

cisapride; oral, rectal

3.9

117.9

373

1033

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

112.9

579

2173

A02BA04

ATC

nizatidine; systemic

3.7

110.2

386

1145

A02BC04

ATC

rabeprazole; oral

3.7

105.4

358

1039

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

103.8

495

1777

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

101.9

747

3361

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.6

99.8

366

1117

K20

ICD-10 Finland

Oesophagitis

17.6

99.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.2

98.6

442

1528

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

96.0

690

3066

R11

ICD-10 Finland

Nausea and vomiting

3.4

95.9

382

1228

N03AX16

ATC

[U] pregabalin

2.4

95.7

898

4508

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

93.3

978

5139

R06.0

ICD-10 Finland

Dyspnoea

2.2

90.4

1022

5528

A02BA03

ATC

famotidine; systemic

4.8

87.0

202

439

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

85.9

834

4221

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

84.8

1626

10676

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.1

81.5

178

367

R07.3

ICD-10 Finland

Other chest pain

2.9

80.1

427

1619

K29.8

ICD-10 Finland

Duodenitis

402.1

79.2

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

+∞

78.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

78.3

595

2692

C03CA01

ATC

furosemide; systemic

2.0

78.3

1229

7454

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

14.6

77.7

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

7.2

76.4

115

165

P01AB01

ATC

metronidazole; oral, rectal

2.0

75.1

1334

8419

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.5

74.1

276

846

UJF92

NOMESCO Finland

Capsular endoscopy

7.0

73.5

114

169

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

11.8

73.3

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.2

72.7

828

4433

K22.1

ICD-10 Finland

Ulcer of oesophagus

127.9

70.2

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.6

70.0

452

1886

N06AX21

ATC

duloxetine; oral

2.6

69.2

436

1796

R51.80

ICD-10 Finland

Headache

2.4

68.7

527

2384

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

67.7

360

1358

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

67.7

431

1784

G44.2

ICD-10 Finland

Tension-type headache

2.5

67.7

482

2106

N06AB04

ATC

citalopram; systemic

2.1

66.9

763

4070

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

231.4

66.5

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

93.4

66.2

R53

ICD-10 Finland

Malaise and fatigue

2.1

65.6

843

4698

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

65.6

708

3693

A06AD11

ATC

lactulose; oral

2.3

64.4

614

3045

N05BA01

ATC

diazepam; systemic, rectal

2.4

63.4

512

2364

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

63.3

427

1815

M54.5

ICD-10 Finland

Low back pain

1.9

63.1

1164

7336

J01DA01

ATC

[U] cefalexin

1.9

62.5

2054

15498

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

62.4

353

1374

N05BA04

ATC

oxazepam; oral

2.0

62.3

911

5305

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

8.5

61.8

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

16.5

61.6

N06AA09

ATC

amitriptyline; systemic

2.6

61.1

383

1570

N03AX12

ATC

[U] gabapentin; oral

2.2

61.0

595

2973

K22.7

ICD-10 Finland

Barrett oesophagus

21.7

60.4

A02BX02

ATC

sucralfate; oral

3.7

59.9

194

541

N05CF01

ATC

zopiclone; oral

1.9

59.8

1145

7277

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

58.4

916

5445

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

155.3

58.1

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.7

57.8

107

N06AX11

ATC

mirtazapine; oral

1.9

57.6

1116

7099

R42

ICD-10 Finland

Dizziness and giddiness

2.0

57.6

821

4719

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

57.6

456

2082

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

3.0

56.9

272

965

J01MA02

ATC

ciprofloxacin; systemic

1.8

56.6

1330

8966

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.4

56.5

213

656

H02AB06

ATC

prednisolone; systemic

1.8

55.4

1569

11155

1310

FHL

Esophagogastroscopy

21.8

55.2

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

54.2

406

1806

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

53.8

253

889

XF402

NOMESCO Finland

ECG with work load test

2.4

53.6

395

1744

C01DA14

ATC

isosorbide mononitrate; oral

2.1

52.8

634

3414

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

51.3

739

4240

N05CD07

ATC

temazepam; oral

2.2

51.0

481

2357

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

50.7

587

3116

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.4

50.4

192

595

M79.6

ICD-10 Finland

Pain in limb

1.8

50.2

1310

9021

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

50.0

490

2438

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

20.2

49.5

R13

ICD-10 Finland

Dysphagia

2.9

49.2

247

899

K85

ICD-10 Finland

Acute pancreatitis

5.7

49.2

168

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

49.0

653

3641

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

48.6

824

4977

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.2

48.2

197

637

C07AB07

ATC

bisoprolol; oral

1.7

47.8

1652

12239

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

47.2

784

4698

R52.9

ICD-10 Finland

Pain, unspecified

2.5

47.1

334

1445

C07AB02

ATC

metoprolol; systemic

1.9

47.0

759

4508

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

46.9

619

3435

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

46.8

1410

10046

R12

ICD-10 Finland

Heartburn

2.8

46.3

246

923

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.2

45.8

187

N05AH04

ATC

quetiapine; oral

2.0

45.3

557

3011

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.5

45.2

113

260

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.9

45.0

226

822

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

44.9

623

3512

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

44.7

970

6288

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.9

44.3

133

351

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

44.3

345

1556

R03AC02

ATC

salbutamol; inhalant

1.7

44.0

1664

12520

N06AX16

ATC

venlafaxine; oral

2.2

43.9

435

2167

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

43.8

596

3334

M03BX02

ATC

tizanidine; oral

1.7

43.8

1884

14649

A01

ICPC

Pain general/multiple sites

2.4

43.3

322

1422

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

43.2

718

4288

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

43.2

377

1784

K86.1

ICD-10 Finland

Other chronic pancreatitis

9.3

43.1

D02

ICPC

Abdominal pain epigastric

3.0

42.8

195

672

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

42.7

1217

8486

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

42.6

278

1156

AA1AD

NOMESCO Finland

CT of head and brain

1.8

42.4

922

5965

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

42.4

430

2160

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

42.4

893

5725

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

42.3

253

1008

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

42.2

154

464

C03DA01

ATC

spironolactone; oral

2.1

42.0

447

2287

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

+∞

41.8

A07AA02

ATC

nystatin; oral

2.8

41.7

226

856

M01AB55

ATC

diclofenac, combinations; oral

2.6

41.7

261

1063

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

41.5

255

1029

K59.0

ICD-10 Finland

Constipation

2.8

41.4

213

785

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

41.3

266

1098

N06AX03

ATC

mianserin; oral

3.0

41.1

193

676

SPAT1263

SPAT

Sampling

1.7

40.9

1290

9209

N03AE01

ATC

clonazepam; systemic

2.8

40.8

218

819

N05BA12

ATC

alprazolam; oral

2.3

40.5

352

1660

N02AA05

ATC

oxycodone; systemic

1.9

40.3

628

3665

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.8

40.0

207

765

SPAT1254

SPAT

Administration of medicine

2.0

39.9

510

2785

N02BE01

ATC

paracetamol; systemic, rectal

2.0

39.3

2828

24931

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

39.3

572

3263

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

8.0

39.2

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.8

39.2

121

326

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

39.1

351

1677

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

39.1

1197

8455

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

39.1

548

3088

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

38.6

532

2978

J02AC01

ATC

fluconazole; systemic

1.7

38.5

1125

7843

J01MA12

ATC

levofloxacin; systemic

1.9

38.2

613

3607

F10.24

ICD-10 Finland

Alcohol depence active use

5.6

38.1

130

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.5

38.1

261

1108

A02BDXX, ,

ATC

3.5

38.1

134

394

D01

ICPC

Abdominal pain/cramps general

2.2

38.1

343

1641

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.4

38.0

143

439

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.7

38.0

125

352

K29.2

ICD-10 Finland

Alcoholic gastritis

197.3

37.9

J01FF01

ATC

clindamycin; systemic

1.7

37.7

852

5541

A10AB05

ATC

insulin aspart; parenteral

2.4

37.6

279

1229

A02BX

ATC

Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

5.8

37.4

122

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

37.3

329

1559

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

4.2

37.3

239

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

371.5

37.1

A01AB04

ATC

amphotericin B; local oral

2.8

36.8

190

701

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.5

36.8

131

J01AA02

ATC

doxycycline; systemic

1.7

36.8

2463

20962

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

+∞

36.5

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.1

36.5

154

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

36.4

391

2001

A01AB09

ATC

miconazole; local oral

2.3

36.3

303

1403

K70.1

ICD-10 Finland

Alcoholic hepatitis

11.3

36.2

I50.0

ICD-10 Finland

Congestive heart failure

2.3

36.1

308

1440

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

35.7

1021

7050

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

+∞

35.5

M01AH02

ATC

rofecoxib; oral

2.0

35.4

433

2322

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

35.4

1284

9396

M01AH01

ATC

celecoxib; oral

1.8

35.4

589

3497

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.1

35.3

154

517

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

35.3

177

643

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

35.2

822

5379

R10.0

ICD-10 Finland

Acute abdomen

3.4

35.2

129

390

N03AX09

ATC

lamotrigine; oral

3.1

35.0

148

488

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

351.0

35.0

UKC02

NOMESCO Finland

Cystoscopy

1.9

35.0

552

3222

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

34.9

145

N06AB03

ATC

fluoxetine; oral

2.0

34.8

391

2033

R03BB04

ATC

tiotropium bromide; inhalant

2.1

34.7

359

1811

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

34.4

338

1672

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

34.2

373

1919

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

34.0

650

4017

H02AB07

ATC

prednisone; oral

1.9

34.0

458

2538

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.9

34.0

161

567

ZXD05

NOMESCO Finland

Urgent procedure

1.6

34.0

944

6456

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.6

33.8

116

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.8

33.5

UJF02

NOMESCO Finland

Peroral enteroscopy

12.3

33.3

M54.2

ICD-10 Finland

Cervicalgia

2.3

33.2

256

1146

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

7.0

33.1

SPAT1301

SPAT

No procedures

1.6

33.0

967

6693

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

330.4

32.9

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

330.4

32.9

N07BB01

ATC

disulfiram; oral

3.0

32.9

145

490

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

5.0

32.8

145

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

32.7

283

1329

Angiography of the heart and coronary arteries

2.4

32.7

242

1063

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.2

32.7

C10AC01

ATC

colestyramine; oral

3.8

32.6

264

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

32.4

653

4092

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.0

32.0

I20.09

ICD-10 Finland

Unstable angina

2.4

31.9

220

936

J01DB01

ATC

cefalexin; oral

1.7

31.8

2536

22033

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

31.7

213

896

A10AE04

ATC

insulin glargine; parenteral

2.1

31.6

329

1661

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

31.3

SPAT1104

SPAT

Monitoring of emergency patient

2.4

31.3

234

1033

N05BA02

ATC

chlordiazepoxide; systemic

3.6

31.2

103

291

M48.0

ICD-10 Finland

Spinal stenosis

1.9

31.1

421

2333

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

31.0

260

1205

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

9.3

30.9

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

30.8

212

901

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

12.0

30.8

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.3

30.8

116

357

M25.5

ICD-10 Finland

Pain in joint

1.6

30.6

908

6281

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

30.5

1064

7646

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

30.5

884

6079

N02AC04

ATC

dextropropoxyphene; oral

2.8

30.4

152

551

J01FA06

ATC

roxithromycin; oral

1.6

30.2

1217

9033

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.9

30.2

144

509

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

30.1

1342

10181

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

30.1

342

1782

L04AX01

ATC

azathioprine; systemic

3.0

30.0

138

478

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

29.9

818

5541

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

29.6

347

1828

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

5.7

29.6

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.7

29.6

AN1

Coronary angiography

1.9

29.5

386

2112

M79.1

ICD-10 Finland

Myalgia

1.9

29.5

424

2394

J01FA09

ATC

clarithromycin; systemic

1.6

29.5

879

6079

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

29.3

531

3218

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

29.2

195

817

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.7

29.2

148

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

29.1

108

329

B01AC04

ATC

clopidogrel; oral

1.8

29.1

543

3319

C08CA05

ATC

nifedipine; systemic

2.3

29.0

230

1040

J01EA01

ATC

trimethoprim; systemic

1.6

29.0

814

5544

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

5.6

29.0

100

N06AB06

ATC

sertraline; oral

2.0

28.9

326

1693

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

28.8

184

755

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

3.7

28.8

245

A10AC01

ATC

insulin (human); parenteral

2.1

28.7

274

1337

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

28.7

148

546

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

28.6

371

2023

M02AA07

ATC

piroxicam; topical

1.5

28.5

1131

8341

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

28.3

175

707

SPAT1285

SPAT

Provision of consultation response

2.5

28.3

187

780

M79.7

ICD-10 Finland

Fibromyalgia

3.3

28.3

106

325

M01AX17

ATC

nimesulide; oral

1.6

28.1

762

5139

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

28.1

251

1193

H02AB04

ATC

methylprednisolone; systemic

1.8

27.9

435

2516

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

27.9

188

791

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

27.9

787

5360

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

27.8

143

526

K22.2

ICD-10 Finland

Oesophageal obstruction

78.3

27.8

C08CA01

ATC

amlodipine; oral

1.5

27.7

1227

9248

N03AF01

ATC

carbamazepine; oral, rectal

2.5

27.7

184

769

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

27.7

374

2067

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.1

27.5

116

K55.2

ICD-10 Finland

Angiodysplasia of colon

8.0

27.3

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

27.2

751

5081

N30.0

ICD-10 Finland

Acute cystitis

1.8

27.0

494

2996

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

27.0

233

1092

S06.0

ICD-10 Finland

Concussion

2.0

26.8

331

1773

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

26.8

227

1055

UJC12

NOMESCO Finland

Flexible oesophagoscopy

9.0

26.8

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

273.3

26.8

SPAT1236

SPAT

Informing family of child’s disability

3.6

26.7

248

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

26.7

514

3162

WX002

NOMESCO Finland

Sedation and analgesia

1.7

26.7

595

3810

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

26.7

343

1863

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

26.7

440

2589

L03

ICPC

Low back symptom/complaint

1.6

26.6

779

5342

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.5

26.6

143

A46

ICD-10 Finland

Erysipelas

1.8

26.6

479

2891

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.4

26.4

279

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.9

26.4

204

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

26.4

223

1036

Z50.1

ICD-10 Finland

Other physical therapy

2.4

26.3

183

781

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

26.3

596

3832

J01CA04

ATC

amoxicillin; systemic

1.6

26.2

2425

21181

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.9

26.1

201

A07EA06

ATC

budesonide; oral, local oral

3.0

26.0

115

390

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

26.0

177

749

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

25.9

1213

9217

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

25.8

162

659

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

25.8

123

435

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

25.8

223

1046

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

25.4

1480

11736

R03BA02

ATC

budesonide; inhalant

1.7

25.3

522

3270

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.0

25.3

116

401

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

25.2

131

485

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

25.2

124

446

N05AA02

ATC

levomepromazine; systemic

2.7

25.1

142

549

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

25.1

546

3469

R02

ICPC

Shortness of breath/dyspnoea

1.8

25.1

387

2228

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

25.0

179

774

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.8

25.0

203

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

24.9

1941

16261

I20.00

ICD-10 Finland

Unstable angina

2.9

24.9

117

410

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

24.9

756

5219

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

24.9

651

4337

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

5.3

24.8

N06AA12

ATC

doxepin; systemic

2.4

24.7

177

766

R52.2

ICD-10 Finland

Other chronic pain

2.8

24.6

125

457

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

24.6

150

602

WZC30, ,

SPAT

2.3

24.6

183

805

M01AE02

ATC

naproxen; oral, rectal

1.5

24.6

1621

13136

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

24.4

239

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

24.4

170

726

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.7

24.3

135

517

R03BA01

ATC

beclometasone; inhalant

1.8

24.3

429

2571

J01DA09

ATC

[U] cefadroxil

1.6

24.2

772

5383

A07EC02

ATC

mesalazine; oral, rectal

2.5

24.2

161

673

M01AC06

ATC

meloxicam; systemic, rectal

1.5

24.2

1077

8069

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

24.2

240

1187

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.0

24.1

172

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

24.0

611

4039

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

23.9

345

1945

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

23.8

740

5127

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

23.8

104

350

R63.4

ICD-10 Finland

Abnormal weight loss

2.7

23.8

131

500

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

23.6

321

1774

C07AA05

ATC

propranolol; systemic

1.7

23.6

557

3611

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

23.6

229

1124

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

23.5

259

1333

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

23.3

485

3041

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.5

23.3

151

624

W19

ICD-10 Finland

Unspecified fall

1.9

23.3

315

1738

R03BA05

ATC

fluticasone; inhalant

1.7

23.2

511

3251

R07.0

ICD-10 Finland

Pain in throat

2.3

23.2

178

793

M01AB05

ATC

diclofenac; systemic, rectal

1.5

23.2

1970

16669

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

23.2

422

2549

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.1

23.2

155

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

23.1

206

977

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.8

23.1

110

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

23.0

392

2322

WZC00, ,

SPAT

1.9

23.0

291

1570

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

22.9

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

22.8

1145

8764

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

22.8

163

705

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

22.7

226

1120

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

120.9

22.6

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

22.6

842

6064

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.3

22.6

173

771

A06AC51

ATC

ispaghula, combinations; oral

2.5

22.6

146

603

R03DC03

ATC

montelukast; oral

1.7

22.6

451

2796

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.5

22.4

142

581

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

22.3

158

680

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

22.3

122

464

J01MA14

ATC

moxifloxacin; systemic

1.9

22.3

282

1522

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

22.2

168

744

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.2

22.2

285

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.5

22.2

143

590

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

8.0

22.1

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.1

22.0

207

1003

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.7

21.9

111

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

21.9

1129

8670

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

+∞

21.9

5355X

ICD-9 Finland

Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis

+∞

21.9

WX892

NOMESCO Finland

Monitored bed care

2.0

21.8

236

1205

R51

ICD-10 Finland

Headache

2.5

21.8

145

607

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

21.8

227

1144

N05CF02

ATC

zolpidem; oral

1.7

21.7

498

3199

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

21.6

377

2247

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.0

21.6

252

1322

N06AB10

ATC

escitalopram; oral

1.6

21.5

533

3493

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

5.2

21.4

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

21.4

141

587

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.8

21.3

108

395

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

21.3

281

1537

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

21.3

183

856

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

21.2

565

3765

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

21.2

1523

12411

M04AA01

ATC

allopurinol; systemic

1.7

21.2

430

2674

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

21.2

196

944

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.1

21.1

304

C10AA01

ATC

simvastatin; oral

1.4

21.0

1325

10544

R55

ICD-10 Finland

Syncope and collapse

1.8

21.0

348

2044

R06AE07

ATC

cetirizine; oral

1.4

21.0

1208

9452

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.2

21.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

21.0

720

5083

R50.9

ICD-10 Finland

Fever, unspecified

1.7

20.9

432

2700

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

20.9

207

1024

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

20.8

364

2172

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

37.4

20.8

R01AD08

ATC

fluticasone; nasal

1.5

20.7

760

5439

R04.2

ICD-10 Finland

Haemoptysis

2.6

20.7

120

470

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.8

20.5

101

364

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

20.4

207

1032

H01

ICPC

Ear pain/earache

1.9

20.4

291

1633

G47.3

ICD-10 Finland

Sleep apnoea

1.6

20.4

626

4310

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

20.3

522

3445

D64.8

ICD-10 Finland

Other specified anaemias

3.5

20.3

209

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.1

20.2

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.1

20.2

280

L17

ICPC

Foot/toe symptom/complaint

1.5

20.0

803

5848

A04

ICPC

Weakness/tiredness general

1.7

20.0

416

2601

E87.6

ICD-10 Finland

Hypokalaemia

2.6

20.0

113

437

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

20.0

674

4735

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

57.9

19.9

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

19.9

162

741

A02BX05

ATC

bismuth subcitrate; oral

4.0

19.8

142

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

19.8

233

1225

205

Kela drug reimbursment

Chronic hypertension

1.5

19.8

892

6648

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

19.8

120

481

Z01.3

ICD-10 Finland

Examination of blood pressure

3.9

19.7

147

R03BA08

ATC

ciclesonide; inhalant

1.9

19.7

242

1292

B01AA03

ATC

warfarin; systemic

1.5

19.6

648

4531

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

19.5

728

5219

R00.2

ICD-10 Finland

Palpitations

2.0

19.5

210

1070

SPAT1260

SPAT

Consultation of another employee

1.6

19.5

505

3337

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.7

19.5

108

414

SPAT1058

SPAT

PEF monitoring instruction

1.9

19.4

239

1277

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

19.4

241

1292

JAH01

NOMESCO Finland

Laparoscopy

2.4

19.3

128

535

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

19.3

503

3329

ZX120

NOMESCO Finland

Intravenous

1.8

19.3

284

1608

R03BB01

ATC

ipratropium bromide; inhalant

2.3

19.3

141

616

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

19.2

186

911

F34.1

ICD-10 Finland

Dysthymia

2.7

19.2

101

377

S22.3

ICD-10 Finland

Fracture of rib

2.0

19.1

226

1191

D11

ICPC

Diarrhoea

1.8

19.1

307

1785

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.4

19.1

139

606

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.7

19.1

101

378

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.5

19.0

124

514

SPAT1097

SPAT

Recording of ECG

1.6

19.0

440

2827

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

19.0

345

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

18.9

251

1375

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

18.8

831

6158

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

18.7

396

2488

C09AA05

ATC

ramipril; oral

1.5

18.6

780

5718

L28

ICPC

Limited function/disability (L)

1.6

18.6

554

3779

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.1

18.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

18.5

245

1340

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

18.5

209

1084

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.6

18.5

111

443

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

18.4

154

713

R01AD09

ATC

mometasone; nasal

1.4

18.4

1205

9589

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.0

18.3

D06

ICPC

Abdominal pain localized other

1.9

18.3

226

1209

B80

ICPC

Iron deficiency anaemia

3.1

18.2

239

UJH02

NOMESCO Finland

Anoscopy

2.4

18.2

126

537

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.4

18.2

125

531

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

18.2

208

1083

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

18.2

342

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

18.1

337

J46

ICD-10 Finland

Status asthmaticus

2.8

18.1

343

A12BA01

ATC

potassium chloride; oral

2.1

18.1

166

797

F45.0

ICD-10 Finland

Somatization disorder

14.4

18.1

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

18.0

189

954

XJC10

NOMESCO Finland

Oesophageal pH monitoring

33.1

17.9

R51.81

ICD-10 Finland

Facial pain NOS

3.1

17.9

247

M01AX01

ATC

nabumetone; oral

2.3

17.8

135

599

L01

ICPC

Neck symptom/complaint

1.6

17.8

403

2573

M54

ICD-10 Finland

Dorsalgia

1.7

17.8

324

1952

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

17.7

272

1559

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

17.7

397

2528

R60.0

ICD-10 Finland

Localized oedema

1.7

17.7

365

2275

N03AG01

ATC

valproic acid; systemic, rectal

2.1

17.7

172

845

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

17.6

228

1239

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

17.6

1975

17131

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

17.6

460

3043

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

17.6

111

454

R06.4

ICD-10 Finland

Hyperventilation

4.0

17.5

128

SPAT1240

SPAT

Therapeutic discussion

1.8

17.5

254

1431

SPAT1310

SPAT

Counselling related to known health issue

1.4

17.5

878

6650

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.1

17.5

115

N05AB01

ATC

dixyrazine; systemic

4.1

17.5

115

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

15.7

17.5

N05BE01

ATC

buspirone; oral

2.8

17.4

316

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

17.4

1018

7922

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.5

17.4

111

456

J01FA10

ATC

azithromycin; systemic

1.4

17.4

1528

12727

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

17.4

978

7560

J01CA08

ATC

pivmecillinam; oral

1.4

17.4

1109

8763

H92.0

ICD-10 Finland

Otalgia

2.2

17.4

156

743

Z51.88

ICD-10 Finland

Other specified medical care

3.0

17.3

268

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

17.3

399

2560

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

17.3

789

5871

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

17.2

335

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

17.2

221

1197

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

17.2

169

833

N02BF02

ATC

pregabalin; oral

2.1

17.2

166

813

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

17.2

195

1013

S18

ICPC

Laceration/cut

1.4

17.2

1308

10639

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.4

17.1

121

521

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

17.1

308

1850

E0000UV, ,

ATC

1.4

17.1

1144

9108

T90

ICPC

Diabetes non-insulin dependent

1.5

17.0

700

5102

E000001, ,

ATC

1.5

16.9

543

3759

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

16.9

127

P15

ICPC

Chronic alcohol abuse

2.8

16.9

305

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.4

16.8

179

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.2

16.8

144

673

N06AB05

ATC

paroxetine; oral

2.1

16.8

163

800

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

14.1

16.8

D07AC01

ATC

betamethasone; topical

1.4

16.8

1017

7955

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

16.7

241

1355

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

16.7

135

616

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.9

16.7

279

A10BA02

ATC

metformin; oral

1.4

16.6

856

6504

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.8

16.6

133

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

16.6

216

Z01.7

ICD-10 Finland

Laboratory examination

1.6

16.6

399

2585

Z2446

NOMESCO Finland

Social worker

2.0

16.5

182

935

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

3.7

16.5

138

K28.9

ICD-10 Finland

Gastrojejunal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

170.8

16.5

6241

FHL

Fund application (Nissen)

170.8

16.5

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.7

16.5

143

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

16.5

189

986

J20

ICD-10 Finland

Acute bronchitis

1.8

16.4

277

1632

V03AA01, ,

ATC

3.6

16.4

153

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.4

16.3

178

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

16.2

228

1271

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

16.2

241

1367

P03

ICPC

Feeling depressed

1.9

16.2

212

1155

C10AA05

ATC

atorvastatin; oral

1.4

16.2

1244

10102

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

16.2

386

2493

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

16.2

267

A10AE05

ATC

insulin detemir; parenteral

2.1

16.1

163

812

R35

ICD-10 Finland

Polyuria

1.9

16.1

201

1078

M02AA10

ATC

ketoprofen; topical

1.6

16.1

465

3142

K50.8

ICD-10 Finland

Other Crohn disease

4.1

16.1

109

R05

ICD-10 Finland

Cough

1.5

16.1

565

3983

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

16.1

1011

7944

T89

ICPC

Diabetes insulin dependent

2.4

16.0

112

480

M54.1

ICD-10 Finland

Radiculopathy

2.3

16.0

122

543

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

16.0

334

2086

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

11.7

16.0

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

16.0

357

2269

A10AB01

ATC

insulin (human); parenteral

2.4

16.0

106

444

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

16.0

407

2673

A07AA09

ATC

vancomycin; oral

3.7

15.9

137

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.7

15.8

327

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

15.8

309

1897

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

15.8

1983

17355

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

15.8

540

3786

B01AB05

ATC

enoxaparin; parenteral

1.4

15.8

905

6997

Catheterization and pressure measurement of the left side of the heart

3.2

15.8

202

A11CC03

ATC

alfacalcidol; systemic

2.8

15.7

294

PD5AD

NOMESCO Finland

CT of aorta

3.0

15.7

234

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

15.7

1229

10001

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

15.6

280

1678

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

+∞

15.6

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

15.5

291

1766

C05AA08

ATC

fluocortolone; rectal, topical

1.6

15.5

380

2471

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.1

15.5

204

K22.0

ICD-10 Finland

Achalasia of cardia

160.7

15.5

C10AA03

ATC

pravastatin; oral

1.9

15.5

216

1202

R33

ICD-10 Finland

Retention of urine

1.8

15.5

250

1455

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

15.4

191

1024

J45

ICD-10 Finland

Asthma

1.7

15.3

271

1618

SPAT1262

SPAT

Handing over of treatment supplies

1.5

15.3

505

3511

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

15.3

108

465

A03DA02

ATC

pitofenone and analgesics; systemic

2.9

15.3

254

N02BF01

ATC

gabapentin; oral

1.8

15.2

221

1245

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.5

15.2

381

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

15.2

170

879

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

15.2

298

1831

Z00.8

ICD-10 Finland

Other general examinations

1.9

15.2

211

1173

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

2.4

15.2

102

430

J01MA06

ATC

norfloxacin; oral

1.6

15.2

382

2500

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

15.1

180

952

L04AD01

ATC

ciclosporin; systemic

3.3

15.0

177

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

15.0

131

617

SPAT1255

SPAT

Intravenous administration of medicine

1.9

15.0

207

1148

WX704

NOMESCO Finland

Intubation

1.8

15.0

223

1266

K55.8

ICD-10 Finland

Other vascular disorders of intestine

10.9

15.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

15.0

268

J01DA06

ATC

[U] cefuroxime

1.6

14.9

392

2590

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

3.9

14.9

111

H25.8

ICD-10 Finland

Other senile cataract

1.6

14.9

345

2211

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

14.9

110

484

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

14.9

1165

9459

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

14.8

122

561

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

14.8

264

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

31.8

14.8

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

14.8

219

1242

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

14.7

237

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

14.7

122

563

R52.0

ICD-10 Finland

Acute pain

2.5

14.7

387

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

14.7

159

812

ZXA00

NOMESCO Finland

Right side

1.4

14.7

780

5940

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

14.6

249

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

14.6

119

545

N06AA04

ATC

clomipramine; systemic

3.3

14.6

165

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

14.6

524

3705

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.7

14.6

300

N07BA03

ATC

varenicline; oral

2.2

14.6

127

598

JKA20

NOMESCO Finland

Cholecystectomy

2.5

14.5

384

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.8

14.5

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

14.5

261

1567

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

14.4

137

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

36.2

14.4

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

36.2

14.4

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

14.4

381

2521

A10AB04

ATC

insulin lispro; parenteral

2.5

14.4

361

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

14.4

148

743

N05AF03

ATC

chlorprothixene; systemic

2.7

14.4

291

R03AC03

ATC

terbutaline; inhalant

1.6

14.4

373

2458

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

14.3

214

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

14.3

135

656

107

Kela drug reimbursment

Pernicious anaemia

3.0

14.2

204

XJ110

NOMESCO Finland

Respiratory helicobactery test

19.2

14.2

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.9

14.2

106

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.3

14.2

105

462

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

14.2

204

1146

E86

ICD-10 Finland

Volume depletion

2.6

14.2

322

WVA20, ,

SPAT

2.7

14.2

293

SPAT1312

SPAT

General health counselling

1.4

14.1

824

6369

K66.0

ICD-10 Finland

Peritoneal adhesions

6.4

14.1

S01BC05

ATC

ketorolac; ophthalmic

2.1

14.1

135

660

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

14.1

286

1773

M01AH05

ATC

etoricoxib; oral

1.3

14.1

1704

14716

R96

ICPC

Asthma

1.7

14.0

261

1580

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

14.0

232

1359

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

14.0

324

A01AB10

ATC

natamycin; local oral

2.4

14.0

378

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

14.0

161

841

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.9

14.0

Z72.1

ICD-10 Finland

Alcohol use

3.9

13.9

103

S20.2

ICD-10 Finland

Contusion of thorax

2.0

13.9

152

779

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.9

632

4677

J01MA01

ATC

ofloxacin; systemic

1.7

13.9

242

1440

L99

ICPC

Musculoskeletal disease other

2.9

13.8

229

R07.2

ICD-10 Finland

Precordial pain

2.7

13.8

268

R25.2

ICD-10 Finland

Cramp and spasm

2.7

13.8

268

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

5.6

13.8

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

13.8

274

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

13.8

231

1358

SFA10

NOMESCO Finland

One-surface restoration

1.3

13.7

1442

12188

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.8

13.6

248

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

13.5

148

SPAT1241

SPAT

Extensive assessment of psychosocial situation

4.7

13.5

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

4.7

13.5

P01

ICPC

Feeling anxious/nervous/tense

1.7

13.5

229

1352

K08.80

ICD-10 Finland

Toothache NOS

1.8

13.4

208

1195

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.0

13.4

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.0

13.4

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.8

13.4

228

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

13.3

314

G04CA02

ATC

tamsulosin; oral

1.4

13.3

685

5175

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.7

13.2

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

13.2

117

556

N06AG02

ATC

moclobemide; oral

2.1

13.1

121

583

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

13.1

427

M10.9

ICD-10 Finland

Gout, unspecified

1.8

13.1

201

1152

C08DA01

ATC

verapamil; systemic

2.0

13.1

133

665

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.6

13.1

282

K08.3

ICD-10 Finland

Retained dental root

1.8

13.0

212

1236

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

13.0

172

941

Z01.2

ICD-10 Finland

Dental examination

1.3

13.0

1140

9364

A11

ICPC

Chest pain NOS

1.7

13.0

219

1290

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

12.9

683

5180

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.9

12.9

216

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

12.9

393

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.4

12.8

382

M54.8

ICD-10 Finland

Other dorsalgia

2.1

12.8

116

556

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

12.8

212

1244

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

12.7

170

933

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

3.7

12.7

110

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

5.8

12.7

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

12.7

615

4595

N04BC05

ATC

pramipexole; oral

1.8

12.7

211

1239

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.4

12.7

365

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

12.7

128

639

R52.1

ICD-10 Finland

Chronic intractable pain

4.3

12.6

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

12.6

276

1743

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

12.6

187

1061

SPAT1153

SPAT

Removal of sutures

1.4

12.6

882

6999

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

12.6

145

758

I86.4

ICD-10 Finland

Gastric varices

70.1

12.6

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.6

12.6

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

12.6

176

S80.0

ICD-10 Finland

Contusion of knee

1.8

12.5

188

1070

5354X

ICD-9 Finland

Gastritis and duodenitis, Other specified gastritis

+∞

12.5

I50.1

ICD-10 Finland

Left ventricular failure

1.9

12.5

160

867

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.6

12.5

277

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

5.2

12.5

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.2

12.5

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

9.3

12.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

12.4

157

847

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768797) Stomach Pathology biopsy report

786

2196

4.39

255.83

1.4

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1476

7298

2.86

183.47

3.7

2.3

54.44

59.39

u/l

2.64

1364

6695

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1981

12854

2.37

121.69

7.3

6.0

10.99

11.82

umol/l

1.72

1898

12171

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1130

6113

2.30

102.18

3.0

2.1

3.39

2.97

mg/l

5.61

1005

5152

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1544

9691

2.12

94.07

5.5

3.5

35.05

99.74

ng/l

0.80

1153

6879

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1533

9946

2.02

81.70

3.8

2.6

125.70

139.22

ug/l

0.85

1444

9142

(3006315) Basophils [#/volume] in Blood

1744

12150

1.93

72.40

7.1

5.5

0.04

e9/l

0.15

1572

10419

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1815

12823

1.93

72.12

8.3

6.4

1.20

1.21

mmol/l

6.70

1588

10785

(3024561) Albumin [Mass/volume] in Serum or Plasma

1610

10950

1.93

71.60

6.2

4.6

34.79

35.28

g/l

2.75

1520

10144

(3001604) Monocytes [#/volume] in Blood

1737

12125

1.92

71.25

7.1

5.5

0.60

0.59

e9/l

0.85

1571

10398

(3013115) Eosinophils [#/volume] in Blood

1783

12600

1.91

69.95

7.4

5.7

0.20

0.19

e9/l

1.98

1622

10926

(3019198) Lymphocytes [#/volume] in Blood

1764

12467

1.90

68.70

7.2

5.6

1.90

1.93

e9/l

0.20

1620

10908

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1230

7737

1.94

68.31

2.6

2.1

175.50

217.06

u/l

1.07

1159

7207

(3022217) INR in Platelet poor plasma by Coagulation assay

1719

12084

1.89

67.69

21.1

16.1

1.32

1.31

inr

0.08

416

3518

(3048689) Calprotectin [Mass/mass] in Stool

529

2416

2.42

67.41

2.7

2.1

171.51

151.40

ug/g

0.43

445

1893

(40760892) CBC W Ordered Manual Differential panel - Blood

1643

11400

1.89

67.22

7.8

6.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2462

19532

2.05

66.82

10.1

7.1

79.73

79.32

u/l

0.18

2352

18321

(3013826) Glucose [Moles/volume] in Serum or Plasma

2016

14968

1.90

66.41

6.5

4.4

6.98

6.76

mmol/l

3.94

1921

14041

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1657

11576

1.87

65.88

7.4

5.8

1.20

1.21

mmol/l

6.11

1537

10507

(3022948) Iron [Moles/volume] in Serum or Plasma

721

3791

2.16

65.44

3.1

2.4

12.21

12.98

umol/l

1.38

674

3526

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1515

10334

1.87

64.53

2.3

1.9

93.19

94.32

pmol/l

0.39

848

5238

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

910

5279

2.00

63.00

1.8

1.7

1.18

1.27

mg/l

0.34

705

4060

(3013650) Neutrophils [#/volume] in Blood by Automated count

1936

14326

1.86

62.87

9.7

8.8

4.28

4.16

e9/l

1.45

1744

12398

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1192

7587

1.90

62.57

3.6

3.0

1895.68

1644.92

ng/l

0.53

1044

6513

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1206

7714

1.89

62.28

4.1

3.1

34.15

38.43

u/l

0.90

1143

7322

(3004789) Transferrin [Mass/volume] in Serum or Plasma

669

3499

2.15

61.10

3.0

2.4

2.41

2.29

g/l

5.88

624

3237

(3013707) Erythrocyte sedimentation rate by Westergren method

2349

18571

1.94

61.09

5.6

3.8

13.75

12.91

mm/h

1.94

2194

17095

(3037522) Nuclear Ab [Titer] in Serum

589

2954

2.21

59.69

1.4

1.3

724.55

526.79

titre

1.17

123

601

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

315

1185

2.83

59.31

2.7

2.3

—

(3019150) Specific gravity of Urine by Refractometry

906

5363

1.95

58.46

5.9

4.0

1.02

kg/l

2.12

205

780

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

401

1716

2.52

58.38

2.0

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

632

3297

2.14

57.79

3.1

2.5

20.84

22.74

2.28

541

2804

(3019309) Folate [Moles/volume] in Red Blood Cells

828

4788

1.98

56.99

2.0

1.7

1242.03

1185.87

nmol/l

0.87

669

3559

(3023368) Bacteria identified in Blood by Culture

1102

7108

1.83

53.57

5.1

4.2

—

(3015736) pH of Urine

1412

9865

1.76

51.90

4.9

3.3

5.72

5.81

0.44

624

(3003396) Base excess in Arterial blood by calculation

563

2933

2.11

51.11

6.6

7.1

1.41

1.17

mmol/l

0.73

452

2314

(3031040) Bacteria [#/volume] in Urine by Automated count

2123

16715

1.77

50.41

6.3

4.4

6075.83

1636.94

e6/l

0.51

254

(3027801) Oxygen [Partial pressure] in Arterial blood

561

2944

2.09

49.85

6.6

7.1

11.45

12.20

kpa

2.88

536

2800

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

561

2945

2.09

49.80

6.6

7.1

5.08

5.10

kpa

0.21

537

2806

(3000570) Elastase.pancreatic [Mass/mass] in Stool

192

600

3.34

49.71

1.5

1.4

262.22

281.46

ug/g

0.59

112

355

(3019060) Gas panel - Arterial blood

379

1701

2.39

49.37

5.4

4.4

—

(3023520) Reticulocytes [#/volume] in Blood

435

2101

2.23

47.63

2.7

2.5

74.99

67.75

e9/l

3.20

355

1555

(3016502) Oxygen saturation in Arterial blood

509

2618

2.12

47.53

6.9

7.5

95.11

95.57

0.76

492

2522

(3027945) Reticulocytes/100 erythrocytes in Blood

533

2794

2.08

47.31

2.4

2.02

1.76

4.86

470

2468

(3021960) Folate [Moles/volume] in Serum or Plasma

923

5870

1.80

45.58

1.7

1.5

19.35

20.51

nmol/l

1.48

819

4998

(3008152) Bicarbonate [Moles/volume] in Arterial blood

356

1624

2.34

44.50

8.3

6.4

24.78

24.60

mmol/l

0.38

346

1546

(3006504) Eosinophils/100 leukocytes in Blood

1545

11383

1.68

44.47

7.6

5.7

2.92

2.83

0.77

1449

10623

(3012544) pH of Venous blood

470

2418

2.10

43.61

4.4

3.4

7.37

7.39

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

572

3165

1.98

43.39

6.7

5.6

1.04

1.03

mmol/l

0.05

532

2921

(3026008) Bacteria identified in Urine by Culture

1162

7978

1.71

43.34

3.8

3.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

450

2287

2.12

43.08

2.8

2.3

4.82

7.71

ug/l

4.67

387

1993

(3013139) Helicobacter pylori Ag [Presence] in Stool

297

1267

2.48

43.07

1.3

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

865

5474

1.79

43.03

1.8

1.7

438.91

26445416.35

pmol/l

3.71

721

4481

(3002032) Base excess in Venous blood by calculation

455

2327

2.11

42.84

4.4

3.4

1.90

1.96

mmol/l

0.14

389

1958

(3019069) Monocytes/100 leukocytes in Blood

1543

11443

1.66

42.69

8.3

6.0

8.57

8.71

0.88

1451

10693

(3018010) Neutrophils/100 leukocytes in Blood

1553

11540

1.66

42.60

7.4

5.7

58.06

57.74

0.47

1461

10798

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

766

4699

1.82

42.15

1.3

1.2

2.34

1.90

u/ml

0.26

216

1258

(3021447) Carbon dioxide [Partial pressure] in Venous blood

454

2334

2.10

42.12

4.5

3.3

5.85

5.84

kpa

0.10

439

2261

(3020779) Urea [Moles/volume] in Serum or Plasma

429

2161

2.13

41.97

8.3

6.9

10.62

10.29

mmol/l

0.41

411

2041

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

493

2636

2.02

41.03

3.4

2.6

8.37

9.11

umol/l

0.30

432

2291

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2000

15937

1.65

40.93

4.4

2.8

60.38

49.96

u/l

3.37

1865

14711

(3024354) Oxygen [Partial pressure] in Venous blood

393

1935

2.17

40.70

4.1

2.7

4.31

4.54

kpa

1.81

380

1872

(3002030) Lymphocytes/100 leukocytes in Blood

1564

11734

1.64

40.61

7.7

5.9

26.74

27.29

1.15

1473

10985

(3022096) Basophils/100 leukocytes in Blood

1489

11053

1.64

40.22

7.4

5.8

0.69

0.67

1.14

1393

10296

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1393

10225

1.63

38.98

2.6

2.1

76.20

78.49

nmol/l

2.37

1257

9086

(3037467) Urinalysis macro (dipstick) panel - Urine

2127

17349

1.64

38.43

6.0

4.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

511

2834

1.95

38.11

2.0

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

262

1116

2.46

38.01

1.5

1.7

1.51

1.57

g/l

0.40

225

948

(3035350) Ketones [Presence] in Urine by Test strip

1617

12369

1.61

37.77

5.3

3.6

0.00

estimate

1.15

242

2539

(3027273) Bicarbonate [Moles/volume] in Venous blood

276

1214

2.39

37.29

4.6

3.0

25.10

25.27

mmol/l

0.36

265

1173

(3004119) Hemoglobin [Mass/volume] in Venous blood

326

1541

2.24

37.23

4.1

2.9

127.06

128.98

g/l

0.80

312

1499

(3002173) Hemoglobin [Mass/volume] in Arterial blood

453

2432

2.00

37.03

7.5

7.9

119.48

121.62

g/l

1.31

446

2368

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

182

658

2.87

36.61

1.7

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1537

11678

1.60

36.48

3.3

2.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1300

9514

1.61

35.96

5.7

3.8

—

(3013512) EKG study

1054

7330

1.65

35.87

5.5

3.8

—

(3009261) Glucose [Presence] in Urine by Test strip

1622

12515

1.59

35.80

5.5

3.6

0.00

estimate

0.80

234

2300

(40761535) Cells panel - Urine sediment

408

2146

2.03

35.23

4.3

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

669

4136

1.78

35.07

1.5

1.4

2.66

2.49

g/l

1.11

434

2473

(3012095) Magnesium [Moles/volume] in Serum or Plasma

653

4011

1.78

34.99

3.6

3.1

0.80

0.82

mmol/l

3.18

612

3724

(3021601) Nitrite [Presence] in Urine by Test strip

1598

12353

1.57

34.51

7.2

4.8

0.00

estimate

0.50

237

2352

(3025941) Bacteria identified in Stool by Culture

275

1249

2.31

34.47

1.4

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

673

4202

1.76

33.97

2.1

1.8

—

(3020891) Body temperature

240

1038

2.42

33.60

6.6

4.1

—

(3000850) Epithelial cells [#/volume] in Urine

823

5455

1.68

33.31

3.3

2.5

5.53

5.51

e6/l

0.01

762

4887

(3042936) Bacteria identified in Isolate by Culture

579

3488

1.80

32.93

2.5

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

491

2811

1.88

32.91

3.9

4.4

232.94

251.62

u/l

2.48

459

2653

(3044640) Blood type and Crossmatch panel - Blood

1098

7852

1.60

32.66

3.1

2.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1193

8712

1.58

32.38

2.9

3.4

2.34

2.36

mmol/l

4.82

1060

7647

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

307

1500

2.15

32.14

1.7

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

388

2073

1.99

31.91

2.2

377.80

376.06

nmol/l

0.06

357

1894

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

758

4986

1.68

31.31

5.4

3.6

172.08

632.48

ng/l

1.76

595

4026

(3026493) Urate [Moles/volume] in Serum or Plasma

942

6568

1.61

30.77

3.2

2.6

4534.79

5679.98

umol/l

0.34

824

5716

(3022145) Colonoscopy Study observation

438

2467

1.90

30.75

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

408

2268

1.91

29.77

2.6

2.0

0.20

0.21

g/l

2.61

377

2104

(40758558) Short blood count panel - Blood

892

6221

1.60

28.75

6.9

6.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

322

1677

2.02

28.34

3.0

2.7

10.41

10.43

g/l

0.02

294

1524

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2233

19027

1.55

28.25

4.8

3.9

14.98

14.86

pmol/l

1.40

2069

17157

(3000991) Gas panel - Venous blood

372

2040

1.93

28.20

7.2

8.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

392

2189

1.90

28.13

5.9

7.0

1.41

1.33

mmol/l

0.83

381

2140

(3018418) pH of Serum or Plasma

1062

7741

1.55

28.10

5.0

3.9

7.40

0.11

178

1482

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

617

3946

1.69

27.97

1.3

1.2

26.55

34.87

iu/ml

1.12

211

1244

(3007566) Smooth muscle Ab [Titer] in Serum

149

560

2.74

27.85

1.3

1.2

112.50

93.90

titre

0.28

(3011397) Hemoglobin [Presence] in Urine by Test strip

846

5877

1.59

27.53

5.0

3.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

265

1299

2.13

27.42

1.8

1.9

1.37

1.41

g/l

0.11

241

1173

(4200892) Spirometry reversibility

321

1691

2.00

27.33

1.6

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

127

449

2.90

26.62

3.0

2.3

31.95

36.02

umol/l

0.83

119

401

(3030467) Casts [#/volume] in Urine by Automated count

992

7195

1.54

26.52

4.1

3.0

0.34

0.46

e6/l

0.86

810

5467

(3020630) Protein [Mass/volume] in Serum or Plasma

375

2108

1.88

26.29

2.4

2.7

66.46

66.27

g/l

0.18

339

1912

(3017315) Amylase [Enzymatic activity/volume] in Urine

5.33

25.59

1.3

1.2

347.62

260.71

u/l

0.17

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

386

2209

1.85

25.54

3.4

2.3

32.86

38.93

u/l

1.11

324

1878

(3026782) Osmolality of Urine

752

5160

1.59

25.49

3.9

2.7

520.48

547.55

mosm/kgh2o

2.91

657

4418

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

478

2920

1.75

25.39

2.0

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

169

711

2.45

25.09

1.5

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

478

2934

1.74

24.94

2.1

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

398

2324

1.81

24.63

1.6

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

581

3772

1.66

24.56

1.3

1.2

10.89

12.60

u/ml

0.23

244

1498

(3002582) Erythrocytes [#/volume] in Urine

1053

7847

1.50

24.35

4.1

3.1

56.64

80.50

e6/l

0.56

866

5995

(36304419) Bacteria [Presence] in Urine

954

6991

1.51

23.80

4.0

3.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

279

1471

1.98

23.61

4.6

3.5

5.20

5.16

kpa

0.25

257

1382

(3018677) aPTT in Platelet poor plasma by Coagulation assay

594

3917

1.63

23.51

2.3

2.1

29.76

29.93

0.25

575

3800

(3009343) pH of Capillary blood

276

1452

1.98

23.50

4.6

3.5

7.42

7.41

0.04

182

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

148

605

2.51

23.38

2.2

183.97

101.29

ug/min

1.02

358

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

213

1022

2.16

23.24

2.3

1.9

2.23

2.56

ug/l

0.15

194

897

(3018095) Leukocytes [#/volume] in Urine

1181

9071

1.47

23.23

4.5

3.5

87.25

117.24

e6/l

0.76

920

6429

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

266

1399

1.98

22.65

4.6

3.5

2.17

1.94

mmol/l

0.41

202

1010

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

830

5980

1.52

22.16

2.8

2.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

330

1879

1.84

22.08

4.3

3.7

100.82

92.60

ng/l

0.73

281

1589

(3003327) Ova and parasites identified in Stool by Light microscopy

149

628

2.44

22.05

1.8

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

292

3.14

21.95

1.7

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

308

1731

1.86

21.46

2.1

2.5

—

(3000494) Fungus identified in Specimen by Culture

445

2800

1.68

20.97

1.6

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

637

4379

1.56

20.91

3.1

2.7

1.05

1.21

e6/l

0.53

424

2461

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

416

2595

1.69

20.21

2.2

1.7

1.66

1.47

3.76

352

2269

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2774

25451

1.59

19.60

24.8

13.8

21.97

25.29

mg/l

7.41

2418

20082

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

517

3476

1.58

18.49

1.7

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1037

8080

1.41

17.69

4.1

3.7

11.56

8.65

mg/mmol

1.06

723

5124

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

107

432

2.53

17.40

8.0

4.7

699.41

4666.29

iu/ml

0.53

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2555

23195

1.46

17.36

5.9

4.6

1.92

2.09

mu/l

1.08

2376

21038

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

202

1062

1.96

17.19

6.1

4.8

1.75

1.64

0.71

195

994

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

141

653

2.21

16.83

1.4

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

200

1056

1.95

16.81

6.2

4.9

0.90

0.89

0.06

193

991

(3015171) Extractable nuclear Ab [Units/volume] in Serum

171

858

2.05

16.60

1.3

1.2

1.06

0.97

u/ml

0.06

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.79

16.58

1.7

2.6

102.16

169.20

umol/l

0.54

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

336

2084

1.68

16.56

2.8

2.5

63.03

65.56

ml/min/173m2

0.61

156

837

(3014765) Yersinia sp identified in Stool by Organism specific culture

141

658

2.19

16.52

1.4

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

884

6769

1.42

16.40

5.9

4.0

0.00

estimate

1.08

225

2253

(3012516) Albumin [Mass/volume] in Urine

983

7679

1.40

16.22

3.6

3.2

535.58

281.28

mg/l

0.84

701

4932

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

485

3305

1.55

16.20

13.2

6.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

424

2813

1.58

15.92

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

140

664

2.16

15.76

1.4

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

127

580

2.24

15.70

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

119

531

2.29

15.55

3.2

2.1

125.82

129.16

g/l

0.51

387

(3047181) Lactate [Moles/volume] in Blood

159

800

2.04

15.33

6.7

5.8

1.51

1.30

mmol/l

1.35

141

710

(3022313) Gas panel - Capillary blood

193

1040

1.91

15.28

4.6

3.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

666

4899

1.45

15.23

2.7

3.1

2.44

2.46

mmol/l

3.09

579

4330

(3004775) Volume in Urine collected for unspecified duration

197

3.14

15.09

2.4

2.2

587.63

628.97

0.34

121

(3016750) Collection duration of Urine

140

3.54

14.71

2.0

505.02

490.93

min

0.54

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

158

806

2.01

14.67

2.9

2.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

211

3.02

14.66

1.1

—

(36660697) Celiac disease serology panel - Serum

274

1663

1.71

14.61

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

151

3.42

14.51

1.5

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

379

2.47

14.40

1.8

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

228

1319

1.78

14.39

6.9

9.7

24.46

24.40

mmol/l

0.10

215

1270

(3019225) pH of Specimen

373

2457

1.58

14.38

4.8

4.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

128

610

2.14

14.26

3.9

3.1

25.20

24.90

mmol/l

0.30

123

597

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

137

671

2.09

14.22

1.9

1.7

—

(3017732) Neutrophils [#/volume] in Blood

262

1583

1.71

14.20

4.7

3.1

6.89

5.64

e9/l

0.34

204

1265

(3005322) IgE [Units/volume] in Serum or Plasma

223

1291

1.78

14.04

1.4

1.3

274.46

229.30

u/ml

0.29

201

1186

(3033658) Prothrombin time (PT) actual/Normal

823

6369

1.39

13.98

5.7

3.7

87.16

89.03

1.25

796

6210

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

105

466

2.29

13.92

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1002

8011

1.36

13.89

3.6

3.1

7.31

7.47

mmol/l

0.58

855

6748

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

345

2.50

13.74

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

232

1369

1.75

13.68

9.3

10.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

6.51

13.64

1.1

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

164

3.21

13.41

2.8

1.3

1.58

1.23

promille

0.75

127

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

121

589

2.09

12.79

1.3

1.2

30.90

44.48

u/ml

0.27

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

170

932

1.87

12.79

1.8

2.5

10.42

10.22

g/l

0.22

147

832

(3006270) Folate [Moles/volume] in Blood

201

2.92

12.75

1.4

1.1

301.38

376.30

nmol/l

1.91

169

(46235355) HIV 1 and 2 tests - Meaningful Use set

472

3358

1.47

12.64

1.8

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

178

994

1.84

12.64

1.8

2.5

7.55

7.48

g/l

0.17

157

901

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

152

812

1.91

12.39

3.1

3.6

80.33

45.69

mg/l

0.47

126

664

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

993

1.83

12.38

1.8

2.5

3.78

3.71

g/l

0.28

156

900

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

994

1.83

12.34

1.8

2.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

152

814

1.91

12.30

3.1

3.6

48.51

55.03

mg/l

0.42

126

663

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

163

895

1.86

12.22

2.2

2.4

283.57

485.83

ug/l

1.48

158

845

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

113

547

2.10

12.14

1.1

5.49

5.69

u/ml

—

(3017181) Myelocytes/100 leukocytes in Blood

322

2138

1.56

11.94

4.5

3.9

1.21

0.85

1.38

129

720

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2556

23661

1.37

11.86

7.5

5.7

41.30

40.08

mmol/mol

7.43

2387

21736

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

380

2621

1.51

11.83

2.9

4.1

6.69

21.27

ug/l

2.87

320

2137

(3000330) Specific gravity of Urine by Test strip

217

1311

1.70

11.77

4.7

3.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

111

541

2.09

11.72

3.8

3.0

7.91

7.96

kpa

0.12

106

529

(3028707) Methadone [Presence] in Urine by Screen method

235

2.67

11.57

3.2

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

294

2.48

11.55

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

123

3.36

11.49

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

119

600

2.02

11.48

3.5

3.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

146

791

1.89

11.42

3.1

3.6

1.37

1.66

ratio

0.26

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

157

876

1.83

11.20

5.1

3.8

24.97

24.84

mmol/l

0.19

143

788

(3003181) Sodium [Moles/volume] in Urine

412

2.22

11.16

1.6

1.3

60.60

61.14

mmol/l

0.04

331

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

110

545

2.05

11.14

1.3

1.2

3.72

2.58

u/ml

0.56

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

153

851

1.84

11.03

2.6

3.5

1012.25

5857.81

u/ml

0.80

133

728

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

124

644

1.96

11.01

1.9

1.5

0.24

g/l

0.12

119

614

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

110

551

2.03

10.82

1.3

1.2

3.86

8.81

u/ml

0.94

(4034850) Laboratory test

154

864

1.82

10.80

17.0

9.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

256

2.53

10.74

1.9

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.92

10.73

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

332

2273

1.51

10.68

4.2

2.9

232.18

217.06

ng/l

0.26

311

2079

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1655

14550

1.28

10.62

3.0

2.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

259

2.50

10.49

2.6

2.3

1.21

1.55

g/24h

0.35

126

(3021901) Oxygen saturation in Capillary blood

451

2.12

10.38

4.1

2.8

—

(3037756) Immunofixation for Serum or Plasma

106

534

2.02

10.28

1.7

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

448

2.11

10.17

1.2

2.58

2.38

u/ml

0.05

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

123

3.20

10.13

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

346

2.25

10.02

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

438

2.11

9.98

1.2

47.56

42.24

u/ml

0.13

(3048929) Epstein Barr virus Ab [Presence] in Serum

111

576

1.96

9.92

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

209

1310

1.64

9.87

2.9

2.7

0.45

0.31

e6/l

0.36

203

1274

(3024980) IgG subclass 4 [Mass/volume] in Serum

323

2.29

9.85

1.6

0.62

0.80

g/l

1.03

240

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

115

606

1.93

9.83

1.6

2.0

10.52

11.24

mg/l

0.49

107

549

(3033705) Calcium.ionized [Moles/volume] in Venous blood

324

2.28

9.78

3.1

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

382

2.18

9.78

1.2

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.80

9.53

2.7

2.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

420

2.10

9.49

1.4

—

17.89

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

931

1.73

9.42

1.9

2.6

2.93

3.01

g/l

0.41

137

837

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

415

2.10

9.39

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

812

6603

1.31

9.33

5.0

3.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

165

987

1.71

9.32

1.7

1.9

39.20

39.13

u/l

0.01

148

851

(3004716) Salmonella sp identified in Stool by Organism specific culture

174

1057

1.68

9.29

1.7

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

332

2.23

9.26

3.1

2.2

4.10

mmol/l

0.02

326

(3035285) Chloride [Moles/volume] in Venous blood

332

2.23

9.26

3.1

2.2

104.64

105.58

mmol/l

0.68

326

(3016879) Cocaine [Presence] in Urine

101

522

1.96

9.16

2.5

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.99

9.04

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

121

668

1.84

8.99

5.5

4.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

127

3.02

8.99

2.3

2.1

50.12

16.00

umol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2800

26576

1.37

8.95

27.9

16.1

139.36

139.68

mmol/l

8.40

2749

25833

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

378

2.12

8.84

1.4

111.47

122.47

u/ml

0.33

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.61

8.82

3.4

2.3

830.36

847.22

e6/l

0.01

(3039000) Anion gap in Blood

107

573

1.90

8.75

7.9

6.6

11.43

11.30

mmol/l

0.13

100

513

(3018572) Chloride [Moles/volume] in Blood

107

573

1.90

8.75

7.9

6.6

104.59

105.25

mmol/l

0.58

100

513

(3027944) Amphetamines [Presence] in Urine

105

559

1.91

8.74

2.5

1.8

—

(1616796) Gas panel - Central venous blood

103

546

1.92

8.69

4.7

3.6

—

(3021589) Normoblasts [#/volume] in Blood

1286

11145

1.25

8.68

13.1

9.3

0.00

e9/l

0.29

1099

9094

(3052851) Hemolysis interference index of Serum or Plasma

129

739

1.78

8.51

3.4

3.2

—

(3000764) Benzodiazepines [Presence] in Urine

105

565

1.89

8.47

2.5

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

306

2.21

8.44

6.6

6.7

12.01

12.06

mg/l

0.03

286

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

167

1031

1.65

8.40

1.1

1.0

—

(3027008) Opiates [Presence] in Urine

105

567

1.88

8.39

2.5

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

275

2.28

8.38

1.1

1.61

1.50

g/l

1.15

249

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

434

2.01

8.37

1.7

1.6

—

(3028300) Cannabinoids [Presence] in Urine

105

571

1.87

8.21

2.5

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

108

594

1.85

8.16

1.8

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2801

26669

1.35

8.09

27.9

16.2

3.99

3.98

mmol/l

1.85

2748

25881

(3010144) Erythrocytes [#/volume] in Synovial fluid

230

2.37

8.01

1.2

1.3

68672.32

55541.20

e6/l

0.08

157

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

167

1046

1.63

7.95

2.0

1.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

256

2.29

7.94

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

396

2.02

7.86

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

396

2.02

7.86

1.8

1.5

—

(3036180) Methadone [Presence] in Urine

3.59

7.84

2.2

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

148

904

1.67

7.78

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

521

4077

1.33

7.74

3.5

2.9

2.11

2.55

e6/l

0.69

315

2170

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

214

1431

1.53

7.71

2.8

3.4

4.23

4.44

pmol/l

2.48

189

1253

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.54

7.69

3.4

2.0

4753.31

3963.68

e6/l

0.10

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

476

1.92

7.69

2.3

1.7

1.04

0.83

nmol/l

1.46

397

(3000012) Reticulocyte production index

379

2.03

7.67

2.9

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

407

1.99

7.65

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

116

669

1.76

7.52

1.3

—

(3000492) Spirometry study

310

2242

1.42

7.51

1.6

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

287

2049

1.44

7.46

4.5

4.0

0.21

0.12

0.71

631

(3021879) Hepatitis B virus core Ab [Presence] in Serum

225

1533

1.50

7.43

1.3

1.4

—

(3023419) Bacteria identified in Sputum by Culture

344

2.06

7.37

2.5

2.4

—

(40761511) CBC panel - Blood by Automated count

2779

26508

1.32

7.31

24.0

12.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

240

2.27

7.31

1.4

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

111

638

1.77

7.29

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

6.83

7.28

1.6

1.8

52.67

23.38

pmol/l

1.75

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

254

2.23

7.23

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

254

2.23

7.23

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

103

581

1.80

7.21

1.5

1.6

14562.32

13938.52

e6/l

0.06

414

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

103

583

1.79

7.13

1.9

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

262

2.20

7.13

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

256

2.21

7.10

1.4

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

272

1948

1.43

6.96

4.5

3.8

0.73

0.65

0.17

102

611

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

119

708

1.71

6.94

1.7

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

103

2.93

6.84

2.2

2.5

43426.86

37884.32

ug/l

0.97

103

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

150

956

1.60

6.70

1.9

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

168

2.46

6.67

1.1

1.0

297.53

287.73

mg/l

0.42

151

(3022621) pH of Urine by Test strip

238

1679

1.45

6.61

4.0

3.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

117

703

1.69

6.60

1.5

1.29

2.22

iu/ml

0.23

147

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

213

2.27

6.55

2.4

2.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

259

2.14

6.51

1.4

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

135

845

1.62

6.51

1.9

2.6

0.43

1.02

g/l

2.62

113

731

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

261

2.13

6.39

1.2

—

nmol/l

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

268

2.11

6.37

1.1

1.2

47.61

31.69

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

282

2.08

6.33

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.46

6.28

3.3

1.4

10.39

14.80

g/l

1.30

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

2.74

6.27

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

222

1563

1.45

6.25

1.8

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.00

6.22

30.8

24.3

127.20

108.04

ug/l

0.81

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

346

1.96

6.21

1.9

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

168

2.40

6.20

1.5

1.9

8.95

6.55

umol/l

0.40

112

(1001926) Buprenorphine [Presence] in Urine by Screen method

440

1.84

6.13

2.9

1.8

—

(3037121) Protein [Mass/volume] in Urine

133

843

1.60

6.11

2.7

3.4

0.54

0.28

g/l

1.02

354

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

126

790

1.62

6.05

1.8

2.3

37.10

37.53

g/l

0.34

105

697

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

386

2995

1.33

6.04

4.9

4.5

33.57

32.46

1.19

282

1957

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

139

893

1.58

6.04

2.8

3.0

0.31

0.35

u/ml

1.02

499

(3042111) Morphology [Interpretation] in Bone marrow Narrative

423

1.84

5.94

2.0

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

290

2.02

5.90

116.3

6.6

8.33

7.26

mmol/l

1.09

250

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

185

2.29

5.87

1.0

—

(3011288) Drugs identified in Urine by Screen method

382

1.88

5.85

4.1

2.8

—

(3025159) Blasts/100 leukocytes in Blood

263

1934

1.39

5.82

4.9

4.0

1.12

0.27

0.45

521

(3004616) Nuclear Ab [Presence] in Serum

251

2.09

5.82

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

3.79

5.81

1.4

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

383

1.87

5.80

1.3

1.2

341.08

261.13

u/ml

1.21

229

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

113

698

1.64

5.78

1.9

2.5

0.00

g/l

-0.00

102

645

(40768804) Tissue Pathology biopsy report

1146

10122

1.20

5.77

2.3

2.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

457

1.79

5.74

1.7

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

119

746

1.62

5.74

1.9

2.5

0.03

0.02

g/l

0.25

108

689

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

132

2.52

5.69

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

132

2.52

5.69

1.1

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

260

2.06

5.69

1.4

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

217

1558

1.42

5.52

2.3

2.4

34.92

24.81

au/ml

—

119

(3024928) Oxygen saturation in Venous blood

525

1.71

5.43

2.4

2.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

265

2.02

5.42

1.1

1.38

2.18

u/ml

0.74

119

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

356

1.87

5.42

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.19

5.31

1.3

1.4

9.11

8.72

ug/l

0.17

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

110

691

1.61

5.29

2.0

2.5

0.00

g/l

-0.00

102

644

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

215

2.11

5.20

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

215

2.11

5.20

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

215

2.11

5.20

1.4

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

117

750

1.58

5.18

1.9

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

139

2.39

5.13

1.1

1.0

—

(3012501) Base excess in Blood by calculation

574

1.66

5.07

5.3

4.4

2.35

2.67

mmol/l

0.65

384

(3010421) pH of Blood

106

669

1.60

5.02

5.4

4.1

7.42

0.01

607

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

280

1.94

5.01

2.1

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

280

1.94

5.01

2.1

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

607

1.63

5.01

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

167

2.23

4.94

1.4

1.2

157.14

86.18

titre

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2602

24901

1.22

4.90

5.5

4.5

6.19

5.98

mmol/l

10.07

2402

22489

(3041672) Baker's yeast Ab [Presence] in Serum

11.45

4.78

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

198

2.08

4.65

1.5

1.3

0.37

0.40

g/l

0.24

139

(3028192) IgG subclass 2 [Mass/volume] in Serum

198

2.08

4.65

1.5

1.3

2.67

2.77

g/l

0.15

139

(3027135) IgG subclass 1 [Mass/volume] in Serum

198

2.08

4.65

1.5

1.3

6.11

6.96

g/l

1.16

139

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

339

1.81

4.61

1.6

1.4

—

(3008295) Osmolality of Serum or Plasma

226

2.00

4.60

1.4

1.3

278.22

277.50

mosm/kgh2o

0.08

169

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

194

1413

1.40

4.59

1.2

1.3

39.38

58.90

au/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.62

4.56

3.0

2.2

20.73

104.90

ug/l

0.50

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2520

24090

1.20

4.55

19.6

13.3

77.76

78.55

ml/min/173m2

0.98

2160

19839

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

431

1.71

4.50

1.8

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

439

1.70

4.49

1.8

1.9

4.70

5.04

mmol/24h

0.41

373

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

485

1.67

4.48

2.7

1.9

7084.58

2632.47

u/l

0.43

201

(3044889) 12 lead EKG panel

1962

18381

1.17

4.47

5.0

3.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.93

4.44

2.4

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

149

2.23

4.43

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.74

4.34

3.2

2.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

144

2.23

4.34

1.5

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

209

1558

1.36

4.31

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

107

2.44

4.29

1.6

2.6

706.04

1212.96

u/ml

0.92

107

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.52

4.28

1.3

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

11.69

4.27

2.0

2.8

3.21

4.20

mg/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

304

1.82

4.26

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

486

1.64

4.20

5.3

3.6

57.66

57.76

0.03

486

(4062490) Immunoglobulin typing, IgG

200

2.01

4.17

1.5

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

279

1.84

4.10

1.9

1.5

—

(3028433) Virus identified in Specimen by Culture

2.71

4.08

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

641

1.55

4.05

1.3

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

175

2.07

4.05

1.3

1.2

—

77.60

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.63

4.05

1.0

1.4

—

(21494755) Public health laboratory ask at order entry panel

145

2013

0.71

4.04

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

162

2.11

4.03

1.1

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

2297

21870

1.17

3.98

26.6

16.5

15.76

14.88

8.39

2275

21401

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

297

1.80

3.95

3.7

2.2

20.27

25.24

mg/l

0.40

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

102

679

1.52

3.91

2.6

2.5

3.62

3.64

g/l

0.05

644

(3023511) Choriogonadotropin [Units/volume] in Urine

263

1.84

3.86

1.3

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

224

1722

1.32

3.80

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

153

2.10

3.78

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

153

2.10

3.78

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

153

2.10

3.78

1.8

1.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

153

2.10

3.78

1.3

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

532

1.57

3.77

4.0

2.4

15.57

16.18

0.69

259

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

525

1.58

3.75

1.7

1.4

—

(44813793) Dust mix specific IgE antibody measurement

147

2.12

3.74

1.3

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

275

2179

1.29

3.73

5.9

3.7

1.23

mmol/l

0.07

248

1878

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

386

1.67

3.71

1.6

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

341

1.71

3.70

1.6

1.4

—

(3045414) Leukocytes [Presence] in Urine

150

1090

1.39

3.66

2.0

1.9

—

(3044927) Protein electrophoresis panel - Urine

246

1.84

3.66

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

261

1.81

3.64

3.4

3.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

156

2.06

3.61

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

156

2.06

3.61

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

156

2.06

3.61

1.3

1.1

—

(3042631) Mycobacterium sp identified in Specimen

337

1.70

3.57

2.3

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

220

1.87

3.54

1.3

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2805

27242

1.21

3.49

15.0

10.0

25.98

26.17

u/l

0.11

2725

26126

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

287

1.75

3.48

1.8

1.5

56.90

61.60

0.30

171

(3021788) Differential panel - Synovial fluid

425

1.61

3.46

1.8

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

132

2.13

3.45

1.2

1.4

5.04

6.65

u/l

1.24

113

(21494434) Karyotype in Bone marrow

209

1.88

3.39

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

134

2.10

3.33

1.8

3.3

—

(3052592) Norovirus Ag [Presence] in Stool

2.92

3.29

1.1

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2497

24048

1.16

3.28

4.7

3.9

1.37

1.30

mmol/l

4.69

2327

21792

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

8.58

3.26

1.3

421.30

467.79

nmol/l

—

(3003338) MCHC [Mass/volume]

2245

21462

1.15

3.25

32.2

17.9

331.16

332.18

g/l

5.81

2230

21254

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

314

2575

1.24

3.22

1.5

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

103

2.24

3.22

1.5

1.4

50.41

62.95

0.83

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

116

2.16

3.22

1.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

116

2.16

3.22

1.2

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

143

2.04

3.20

1.1

1.3

0.84

1.18

u/ml

0.16

(3005570) Glucose [Moles/volume] in Urine

250

1.77

3.20

2.0

—

(40768443) Skin Pathology biopsy report

142

1048

1.37

3.20

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

387

1.61

3.20

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2801

27247

1.19

3.16

27.4

16.3

82.28

78.57

umol/l

4.10

2801

27236

(3008898) HLA-B27 [Presence]

102

712

1.45

3.16

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.36

3.15

1.8

3.0

23.26

30.02

umol/l

1.63

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.41

3.13

1.7

1.4

14.00

15.54

pmol/l

0.51

(3009466) Valproate [Moles/volume] in Serum or Plasma

359

1.63

3.10

4.8

5.0

344.28

358.74

umol/l

0.39

310

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.01

3.08

2.6

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.23

3.05

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.23

3.05

1.6

1.3

—

(40757373) Influenza virus identified in Isolate

2.69

3.05

2.1

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.27

3.03

1.2

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.27

3.03

1.2

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.34

3.01

1.7

1.5

123.53

163.72

ng/l

0.38

(3014051) Protein [Presence] in Urine by Test strip

653

1.45

3.00

2.5

2.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.31

3.00

1.2

8.0

55.45

62.61

mg/l

0.16

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

101

712

1.43

2.99

2.5

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2599

25160

1.16

2.96

5.2

4.4

4.47

4.64

mmol/l

13.32

2436

23132

(3042733) HLA Ab [Presence] in Serum

2.64

2.96

4.2

5.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

589

1.47

2.96

3.1

0.77

0.83

nmol/l

0.70

452

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

557

1.48

2.94

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

557

1.48

2.94

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.22

2.89

1.2

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

266

1.70

2.88

3.3

3.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.70

2.88

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

152

1980

0.76

2.88

1.9

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.68

2.86

2.8

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

185

1448

1.29

2.83

1.2

121.01

157.52

iu/ml

0.50

527

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

353

1.60

2.82

2.1

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2648

25703

1.16

2.77

5.8

4.9

2.60

2.74

mmol/l

11.60

2480

23515

(3019977) pH of Arterial blood

138

1.96

2.74

2.6

7.43

0.03

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

138

1.96

2.74

2.4

2.7

39.35

40.06

0.07

(3014271) Vancomycin [Susceptibility]

145

1.94

2.74

3.5

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

412

1.54

2.72

1.3

1.2

93.65

30.38

u/l

0.56

348

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.72

2.71

1.8

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

118

2.04

2.71

1.6

1.4

—

(3042517) Benzodiazepines panel - Urine

6.01

2.70

3.2

1.2

—

(1761868) Lipid panel - Serum or Plasma

789

8705

0.88

2.66

3.5

2.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.22

2.63

2.1

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

522

1.47

2.61

1.6

99.36

1090.68

e6/l

2.60

425

(3024891) Influenza virus A+B Ag [Presence] in Specimen

641

1.42

2.56

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

633

1.42

2.55

1.4

1.6

278.07

309.10

mu/l

0.75

580

(3036670) Protein [Mass/volume] in Synovial fluid

2.36

2.55

1.1

1.2

35.71

37.33

g/l

—

(3017704) Immunofixation for Urine

142

1.91

2.55

1.3

1.6

—

(3047189) Immunofixation for 24 hour Urine

121

1.99

2.55

2.0

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.46

2.54

3.5

3.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.43

2.53

1.7

1.6

0.53

0.50

ug/l

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.43

2.53

1.3

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

342

0.47

2.52

1.4

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

136

1.92

2.50

1.8

2.7

457.42

483.77

e6/l

0.12

114

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

129

1.95

2.50

1.9

2.8

0.16

0.21

e9/l

0.74

113

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2569

24936

1.14

2.48

5.2

4.3

1.41

1.46

mmol/l

8.98

2407

22788

(3044007) Cell count panel - Peritoneal fluid

2.39

2.46

2.3

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

521

1.45

2.45

1.5

17.08

28.68

e6/l

0.35

405

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

563

1.43

2.45

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.14

2.44

1.9

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.56

2.44

2.5

2.4

155.71

149.17

e6/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.26

2.37

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

534

1.43

2.36

1.3

4.03

3.77

mmol/l

0.68

500

(3006442) Creatine [Moles/volume] in Serum or Plasma

162

1.80

2.31

1.9

1.4

82.38

82.34

umol/l

0.00

162

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

126

1.91

2.30

3.0

3.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

562

1.42

2.30

1.6

1.8

3.46

4.60

iu/l

0.99

185

(3035320) C reactive protein [Mass/volume] in Body fluid

155

1.81

2.29

2.8

2.5

—

(3044941) Cell count panel - Synovial fluid

397

1.50

2.28

1.5

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

452

5126

0.86

2.25

3.0

0.85

0.77

ug/l

0.38

316

3386

(3024471) HLA-A [Type]

2.34

2.21

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

157

1.79

2.21

1.3

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

433

1.46

2.21

4.9

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

368

1.50

2.20

1.7

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

151

1.79

2.15

2.1

2.3

—

(3044009) aPTT.lupus sensitive (LA screen)

3.69

2.15

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

258

1.60

2.15

3.1

2.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

258

1.60

2.15

1.3

25.63

30.50

u/l

0.37

213

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

621

1.38

2.14

3.0

3.1

1.80

1.57

mg/l

1.36

558

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

243

1.61

2.13

1.7

1.4

29.45

31.19

0.09

144

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.21

2.09

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

206

1.66

2.07

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

507

0.61

2.07

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

2.33

2.04

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

704

1.35

2.04

2.4

2.3

96.50

91.17

1.48

679

(3016018) Differential panel - Cerebral spinal fluid

238

1.60

2.04

1.5

—

(3011412) CD3 cells [#/volume] in Blood

207

1.65

2.04

1.9

2.6

1.32

1.08

e9/l

0.71

188

(40768800) Prostate Pathology biopsy report

541

0.62

2.03

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.08

2.01

30.3

7.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

327

1.51

2.01

1.2

3.50

4.62

u/ml

0.42

133

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.64

2.00

2.0

1.6

5.80

6.74

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

1.81

1.99

1.3

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

163

1.72

1.98

1.6

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

171

1.70

1.96

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

546

1.38

1.96

1.1

1.3

221.47

210.80

miu/ml

0.07

248

(3006462) Nitrate [Presence] in Urine

120

1.84

1.92

3.5

3.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

320

0.53

1.91

1.3

1.4

—

(3024932) HLA-DR beta [Type]

2.25

1.90

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

106

1.89

1.90

1.3

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

319

0.53

1.89

1.3

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.19

1.88

1.9

2.9

0.86

0.68

u/field

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

318

0.53

1.87

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

318

0.53

1.87

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

543

1.37

1.86

1.2

1.4

11.02

10.08

u/l

0.17

446

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.40

1.85

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.21

1.84

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

246

1.55

1.81

1.8

1.4

21.60

26.40

iu/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.05

1.80

1.9

1.6

41.57

36.96

umol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

215

1.59

1.79

2.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

272

0.51

1.76

1.4

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.94

1.74

1.0

—

7.43

—

(40768446) Kidney Pathology biopsy report

1.98

1.74

1.9

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.50

1.74

1.3

2.1

—

(40768441) Liver Pathology biopsy report

155

1.68

1.72

1.6

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.67

1.72

3.8

2.1

19.00

20.46

umol/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.92

1.72

1.1

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.85

1.71

1.4

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

415

1.40

1.71

3.0

3.1

0.68

1.33

3.03

358

(3017354) Segmented neutrophils/100 leukocytes in Blood

242

1.53

1.70

3.2

2.9

58.19

56.79

0.14

200

(3048879) Bone marrow aspiration report

2.06

1.70

1.6

1.9

—

(3049717) Cytology report of Urine Cyto stain

126

1012

1.25

1.68

2.8

2.6

—

(40762814) Titanium [Mass/volume] in Blood

2.50

1.66

2.2

4.66

5.13

ug/l

—

(3019174) dRVVT (LA screen)

3.16

1.66

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

220

1.55

1.65

2.1

2.3

—

(3033799) Differential panel - Peritoneal fluid

2.03

1.64

2.2

2.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

127

1.74

1.64

1.8

1.6

2.57

2.26

u/field

0.06

(3047352) Trisomy 18 risk [Likelihood] in Fetus

265

0.53

1.64

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

211

1794

1.19

1.62

1.4

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.15

1.61

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

263

0.53

1.60

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.00

1.59

2.3

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.00

1.59

1.4

1.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.70

1.58

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.70

1.58

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.70

1.58

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

338

1.43

1.57

1.1

0.63

1.91

u/ml

1.60

176

(3017569) Oxygen content in Arterial blood

129

1.71

1.56

3.0

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

474

1.36

1.56

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.28

1.55

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

176

1.60

1.54

2.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

219

0.50

1.52

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.60

1.51

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

124

1.70

1.47

1.0

1.1

—

(3011648) Oxygen content in Venous blood

219

1.51

1.46

1.8

10.93

11.14

0.13

219

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.13

1.44

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.73

1.43

2.3

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

209

1798

1.17

1.43

2.1

2.2

12.48

12.57

nmol/l

0.05

188

1602

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

577

0.71

1.42

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.25

1.40

2.4

3.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

321

1.41

1.40

1.7

1.3

1576.14

1620.81

e6/l

0.03

236

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

119

1.68

1.37

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

102

822

1.25

1.37

1.2

1.3

28.00

30.61

iu/l

0.35

702

(3004451) EKG impression Narrative

127

1.66

1.36

2.1

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

313

2785

1.14

1.36

4.8

3.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.94

1.36

1.0

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.94

1.36

1.2

1.0

4.08

5.50

nmol/l

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

200

1.50

1.32

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

938

8851

1.08

1.30

4.8

4.9

3.27

4.10

ug/l

0.24

834

7921

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

335

1.38

1.29

1.2

2.20

3.98

u/ml

—

111

(3017509) Phencyclidine [Presence] in Urine

2.78

1.28

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.09

1.27

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

202

1.49

1.27

1.8

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

135

0.44

1.27

1.5

1.4

1.68

1.55

g/l

—

135

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.29

1.26

1.0

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.29

1.26

3.9

5.7

—

(3045424) Erythrocytes [Presence] in Urine

405

1.34

1.26

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

162

1.55

1.25

1.4

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

115

1.66

1.24

1.1

140.58

136.83

nmol/l

0.09

115

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.40

1.24

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.23

1.24

12.9

11.7

4.44

5.94

mmol/l

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

123

1.63

1.24

1.7

1.4

4.50

3.24

—

(3050129) First trimester maternal screen panel - Serum or Plasma

386

0.67

1.23

1.3

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

557

1.28

1.22

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

109

1315

0.82

1.22

1.6

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.63

1.21

2.6

1.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.63

1.21

1.0

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

263

1.41

1.20

1.6

1.5

—

(3020491) Glucose [Moles/volume] in Blood

172

1.52

1.20

1.7

2.5

8.09

6.82

mmol/l

0.68

116

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

238

1.43

1.20

1.6

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

140

1.58

1.20

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

275

0.62

1.19

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

173

1.51

1.17

1.2

1.4

176.90

211.53

pmol/l

0.27

173

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

650

1.25

1.17

2.7

2.6

203.25

194.04

0.41

617

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

368

1.34

1.16

1.1

2807.92

1534.43

iu/ml

0.17

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.15

1.0

1.3

11.00

11.70

u/l

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

166

1.51

1.14

1.7

1.4

14.68

13.34

u/l

0.52

158

(40768793) Breast Pathology biopsy report

587

0.75

1.14

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

127

1.58

1.11

6.2

17.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

168

1.49

1.09

1.0

834.37

712.06

ng/l

0.53

(3051611) Lipemic interference index of Serum or Plasma

260

1.39

1.09

3.2

3.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.38

1.09

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.38

1.09

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

139

0.50

1.09

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

286

1.37

1.08

1.1

0.69

1.33

u/ml

0.64

115

(3036489) Thrombin time

107

894

1.20

1.08

2.2

2.1

20.52

21.48

1.71

791

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

304

1.35

1.07

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

356

1.32

1.07

1.8

1.4

30.78

31.96

g/l

0.30

324

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

169

1.48

1.07

1.0

297.32

302.59

ng/l

0.05

103

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.93

1.06

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

137

1.54

1.05

1.8

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

401

1.30

1.05

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

288

1.36

1.05

1.5

1.3

80608.24

84047.22

e6/l

0.02

174

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

170

1.47

1.04

1.0

39.60

40.93

ng/l

0.07

103

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.06

1.03

1.3

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

221

1.41

1.02

1.8

2.0

2.00

2.04

u/field

0.02

(3003888) Timothy IgE Ab [Units/volume] in Serum

298

1.35

1.02

1.1

1.43

4.84

u/ml

1.91

142

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.65

1.00

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

139

1.51

1.00

1.8

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

172

1.46

0.99

1.4

1.5

15.75

12.89

umol/l

0.74

161

(3020874) Milk IgE Ab [Units/volume] in Serum

1.63

0.97

1.1

0.29

0.25

u/ml

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

488

1.25

0.95

2.2

1.9

176.48

205.83

pmol/l

1.96

457

(40765096) Chromosome analysis panel by Banding

1.62

0.93

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

234

1.37

0.93

3.1

3.2

84.18

34.50

mg/l

0.40

177

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.14

0.91

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

296

1.32

0.90

1.3

7.15

7.47

mmol/l

0.20

258

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

818

0.82

0.90

2.3

1.7

3.80

3.33

mg/l

0.21

603

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.07

0.89

2.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

297

1.32

0.89

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

177

1.42

0.88

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.86

0.87

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.72

0.86

1.2

1.5

57.73

190.19

nmol/24h

0.73

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

264

1.33

0.86

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

1.44

0.85

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

213

1.36

0.84

2.1

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.57

0.84

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

205

1.37

0.83

1.0

1.1

3.21

2.74

u/ml

0.07

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.82

0.79

1.2

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.79

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.79

0.0

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.79

0.0

5.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

246

0.69

0.78

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

125

0.56

0.77

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

252

1.31

0.76

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

332

1.27

0.76

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

1.54

0.75

1.1

0.86

1.44

u/ml

—

(3026480) Teichoate Ab [Titer] in Serum

2.08

0.74

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2865

28374

1.08

0.73

36.4

20.4

39.03

40.00

11.40

2662

26364

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

210

1.34

0.73

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.84

0.73

1.0

1.2

—

(3035880) pH of Pleural fluid

150

1.40

0.73

1.6

1.3

—

(3007461) Platelets [#/volume] in Blood

2866

28391

1.08

0.71

36.4

20.3

247.91

247.97

e9/l

0.01

2812

27545

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.92

0.70

1.4

1.3

—

(3024731) MCV [Entitic volume]

2867

28403

1.08

0.70

36.3

20.2

91.25

0.01

2826

27890

(3035941) MCH [Entitic mass]

2867

28403

1.08

0.70

36.2

20.2

30.26

30.37

2.37

2825

27890

(3026361) Erythrocytes [#/volume] in Blood

2867

28407

1.07

0.69

36.4

20.2

4.38

4.48

e12/l

19.25

2807

27463

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.53

0.68

1.0

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.60

0.68

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

266

1.28

0.68

1.1

0.94

1.47

u/ml

0.53

133

(3000963) Hemoglobin [Mass/volume] in Blood

2867

28415

1.07

0.66

36.7

20.4

131.49

135.12

g/l

29.38

2825

27913

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.65

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2866

28408

1.07

0.65

36.5

20.3

7.05

6.76

e9/l

4.52

2806

27454

(3014148) Varicella zoster virus Ab [Titer] in Serum

233

1.29

0.64

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

269

1.27

0.63

1.4

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.63

0.62

1.3

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.67

0.61

1.4

37.80

19.35

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.67

0.61

1.0

1.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.67

0.61

3.0

2.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

1.39

0.61

1.1

0.95

1.15

u/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

164

1489

1.11

0.61

1.5

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.50

0.59

3.3

2.0

—

(3012441) Differential panel - Pleural fluid

263

1.26

0.59

1.8

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

290

1.24

0.59

1.7

2.2

—

3.75

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.53

0.59

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.53

0.59

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.53

0.59

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.51

0.58

1.5

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.48

0.57

1.4

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

220

1.28

0.57

1.8

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

150

1.34

0.55

6.3

6.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.43

0.53

1.5

1.3

133.23

162.92

mmol/24h

1.11

(3023410) Appearance of Cerebral spinal fluid

224

1.25

0.50

1.6

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.50

2.9

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.47

0.50

2.9

2.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

144

1.32

0.50

1.3

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.46

0.50

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.43

0.49

1.0

1.1

2049.33

1538.46

miu/ml

0.79

(40768806) Pleura Pathology biopsy report

280

1.22

0.48

1.6

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

582

0.86

0.48

4.9

3.5

18.40

27.09

mg/l

1.76

373

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.46

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

118

0.68

0.45

1.0

1.2

—

(40761536) Microorganisms panel - Urine sediment

231

2166

1.07

0.45

5.4

3.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

121

1.32

0.44

1.1

1.04

1.03

ratio

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.61

0.43

1.2

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.61

0.43

3.0

3.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

140

1.29

0.42

3.1

2.2

—

(3024263) Appearance of Synovial fluid

149

1.28

0.41

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.38

0.41

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

644

1.12

0.40

1.4

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.31

0.39

2.3

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.41

0.39

1.4

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

193

0.78

0.39

1.1

1.0

0.16

0.27

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.39

0.38

1.0

1.2

40.90

44.63

mg/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

101

1100

0.92

0.36

1.6

1.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.27

0.36

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.27

0.36

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.27

0.36

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.27

0.36

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.64

0.35

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.40

0.35

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

109

1.29

0.33

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

118

1.27

0.33

2.1

2.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

210

1.19

0.32

5.0

5.4

47.62

53.85

u/ml

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.28

0.32

1.0

—

(3051651) Icteric interference index of Serum or Plasma

146

1.23

0.32

3.2

3.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

132

0.76

0.32

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

132

0.76

0.32

1.3

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.35

0.31

1.3

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

142

0.77

0.30

1.1

—

(1002224) Polysomnography panel

931

0.92

0.29

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

358

3453

1.04

0.29

1.5

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.25

0.29

7.3

8.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.23

0.29

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

112

1.25

0.28

2.4

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

1.29

0.28

1.4

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

280

1.14

0.27

1.4

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.23

0.27

1.0

1.2

—

(3034426) Prothrombin time (PT)

0.68

0.26

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.68

0.26

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

1.21

0.25

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.25

0.25

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.24

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.28

0.23

1.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.25

0.22

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.17

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.21

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.4

—

316.00

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.24

0.18

1.5

1.6

—

(3003694) ABO and Rh group [Type] in Blood

658

6692

0.98

0.18

1.3

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.22

0.17

1.7

2.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

295

1.09

0.14

1.0

1.1

—

(4035726) Immunohistochemistry procedure

232

2263

1.03

0.13

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

113

1.15

0.13

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

108

0.83

0.13

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

697

1.05

0.12

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

258

1.09

0.12

1.6

1.9

—

1230.00

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

230

1.09

0.11

1.0

1.1

2.42

2.59

u/ml

0.05

105

(3025130) Human papilloma virus identified in Specimen

270

1.07

0.10

2.1

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

678

6712

1.01

0.10

1.7

1.6

1.49

1.36

mmol/l

2.26

578

5608

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

704

7108

0.99

0.10

4.5

4.3

22.66

21.91

0.64

349

3524

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.06

0.09

1.0

1.1

—

7.43

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.08

0.08

1.0

3.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

205

0.93

0.08

1.3

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.12

0.07

1.0

1.2

—

0.24

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.08

0.02

1.6

2.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

103

1.07

0.02

1.0

1.2

—

(3045788) Cell count panel - Pleural fluid

263

1.03

0.01

1.7

1.4

—

(3002256) Pathology report gross observation

337

3364

1.00

0.00

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

185

1.03

0.00

1.4

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

0.99

0.00

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

331

1.00

0.00

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

267

1.01

0.00

1.4

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.5

—

4046.67

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

38.09

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

7.60

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.91

-0.00

1.0

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.92

-0.00

1.0

2.7

154.78

158.82

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.86

-0.00

1.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

22.06

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.6

—

0.70

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.96

-0.00

1.1

1.0

97.67

91.81

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

8.13

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

330

1.00

-0.00

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.97

-0.00

1.3

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.91

-0.00

10.5

5.8

74.83

71.44

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

44.00

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.90

-0.00

3.4

2.1

1.14

1.08

ug/l

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

2.31

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.28

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.91

-0.00

1.0

1.4

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ACUTGASTR and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ACUTGASTR	1.501 [1.39, 1.62]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.505

During the follow-up period (1.1.1998 — 31.12.2019), 3509 out of 10649 females with K11_ACUTGASTR died.

Males

Parameter	HR [95% CI]	p-value
K11_ACUTGASTR	1.956 [1.79, 2.13]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 3690 out of 9494 males with K11_ACUTGASTR died.

Mortality risk

Mortality risk for people of age

years, who have K11_ACUTGASTR.

N-year risk	Females	Males
1	0.169%	0.302%
5	0.945%	2.288%
10	2.344%	5.938%
15	4.395%	10.628%
20	7.829%	17.594%

Relationships between endpoints

↥

Index endpoint: K11_ACUTGASTR – Acute gastritis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acute gastritis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints